OSU technologies funded for development

May 14, 2008

Stillwater, Okla.--OSU's Technology Business Assessment Group will fund four faculty research projects for spring 2008. The group identified these one-year projects from a number of excellent proposals submitted in response to a solicitation earlier this spring. Funding for the program is administered by the OSU Office of Intellectual Property Management, and is generated by royalties from OSU-licensed technologies. These funded projects show a significant probability of having commercial success.

"We are pleased that the OIPM royalty stream allowed us to hold yet another competition for the spring of 2008," Steve Price, director of OIPM, said. "It's exciting to be able to continue the trend of developing OSU research into viable commercial products."

Created in 2005, TBAG funds projects in need of feasibility demonstration and/or prototype development for commercialization purposes. The group is comprised of private sector partners experienced in new product identification and new technology evaluation, representation from i2E, early-stage capital investors, bankers, representation from Meridian Technology Center for Business Development, the OSU Center for Innovation and Economic Development, the OSU Vice President for Research and Technology Transfer, the OSU Associate Vice President for Technology Development and OSU-Okmulgee.

The OSU research projects selected to receive more than $102,000 from TBAG this year include:
-end-
For more information on the Technology Business Assessment Group, visit http://vpr.okstate.edu/ipm.

Oklahoma State University

Related Endothelial Cells Articles from Brightsurf:

JACC: BTS study looks at COVID-19's impact on cardiovascular tissue, endothelial cells
In the paper, ''Cardiorenal tissues express SARS-CoV-2 entry genes and basigin (BSG/CD147) increases with age in endothelial cells,'' publishing in JACC: Basic to Translational Research, researchers used publicly available gene expression data to determine the relative expression of key SARS-CoV-2 host entry/ processing genes in human cardiorenal tissues, including aorta, coronary artery, heart (atria and left ventricle), whole blood and the kidney and for comparison the colon, spleen and lung.

New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed
Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a new way to kill some multiplying human breast cancer cells by selectively attacking the core of their cell division machinery.

Nutrient deficiency in tumor cells attracts cells that suppress the immune system
A study led by IDIBELL researchers and published this week in the American journal PNAS shows that, by depriving tumor cells of glucose, they release a large number of signaling molecules.

Scientists modify CAR-T cells to target multiple sites on leukemia cells
In a preclinical study, scientists engineer new CAR-T cells to attack three sites on leukemia cells, instead of one.

Sphingotec's endothelial function biomarker bio-ADM® improves risk stratification of sepsis patients at ICUs
New study data show that monitoring blood levels of sphingotec's endothelial function biomarker bio-ADMĀ® on top of guideline parameter lactate improves risk stratification of sepsis patients admitted to intensive care units.

sphingotec's endothelial function biomarker bio-ADM® predicts need for organ support in general ICU patient population
Data from more than 2,000 patients enrolled in the FROG-ICU study demonstrate that high levels of bioactive adrenomedullin (bio-ADMĀ®) predict the need for organ support, ionotropes, and vasopressors in the general patient population at admission to the intensive care unit (ICU).

First-of-its-kind study in endothelial stem cells finds exposure to flavored e-cigarette liquids, e-cigarette use exacerbates cell dysfunction
There has been a rapid rise in e-cigarette use, but its health effects have not been well-studied and their effect on vascular health remains unknown.

Dead cells disrupt how immune cells respond to wounds and patrol for infection
Immune cells prioritise the clearance of dead cells overriding their normal migration to sites of injury.

Transplanted bone marrow endothelial progenitor cells delay ALS disease progression
Transplanting human bone marrow-derived endothelial progenitor cells into mice mimicking symptoms of amyotrophic lateral sclerosis (ALS) helped more motor neurons survive and slowed disease progression by repairing damage to the blood-spinal cord barrier, University of South Florida researchers report.

Revealed: How the 'Iron Man' of immune cells helps T cells fight infection
The immune system's killer T cells are crucial in fighting viral infections.

Read More: Endothelial Cells News and Endothelial Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.